BioSpace News Archive

Genetown

TScan Therapeutics to Host a Virtual Event to Discuss Highlights from the 63rd ASH Annual Meeting and Exposition- Event to feature Dr. Yi-Bin Chen, M.D., M.S., from MGH and Harvard Medical School -

TScan Therapeutics, Inc. today announced that the Company will host a virtual event to discuss highlights from its posters at the 63rd American Society of Hematology (ASH) Annual Meeting and Exposition on Wednesday, December 15, 2021, at 4:30 p.m. ET.

December 3, 2021
·
3 min read
Drug Development

Xenon Pharmaceuticals Presents Additional Positive Data from Phase 2b ‘X-TOLE’ Clinical Trial at the Annual Meeting of the American Epilepsy Society (AES 2021)

Xenon Pharmaceuticals Inc. today announced that additional positive data from new sub-analyses of the Phase 2b X-TOLE clinical trial will be presented in a scientific poster entitled “Phase 2b Efficacy and Safety of XEN1101.

December 3, 2021
·
14 min read
Business

Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors

Enochian BioSciences, Inc. today announced that Dr. Serhat Gumrukçu, Inventor and Co-Founder of Enochian BioSciences, and Founder and Director of Seraph Research Institute (SRI), presented new data and announced a partnership between Enochian and Dr. Anahid Jewett.

December 3, 2021
·
3 min read
Drug Development

Aclaris Therapeutics Announces Publication of Preclinical Research of Zunsemetinib in Pancreatic Cancer in Science Translational Medicine

Aclaris Therapeutics, Inc. today announced the publication of preclinical research of zunsemetinib in pancreatic cancer in the peer-reviewed journal Science Translational Medicine, on December 1, 2021.

December 3, 2021
·
4 min read
Business

Nanoscope Therapeutics Wins ‘Top Retina Company’ Award at 2021 Eyecelerator Conference for Its Optogenetics Gene Therapy to Restore Vision in People Blinded by Retinal Diseases

Nanoscope Therapeutics Inc. was awarded as the Top Retina Company at the Eyecelerator conference at the 2021 meeting of the American Academy of Ophthalmology (AAO) in New Orleans, LA .

December 3, 2021
·
2 min read
Biotech Beach

Tryp Therapeutics to Present at the H.C. Wainwright Psychedelics Conference on December 6, 2021

Tryp Therapeutics announced today that it will present at the 2nd Annual H.C. Wainwright Psychedelics Conference.

December 3, 2021
·
3 min read
Vivos Therapeutics to Participate at the Benzinga Global Small Cap ConferenceVivos management to present at 1:55 pm Eastern Time on December 9, 2021

Vivos Therapeutics, Inc. today announced that Vivos’ Chairman and Chief Executive Officer, Kirk Huntsman, and Vivos’ Chief Financial Officer, Brad Amman, will be presenting at the online Benzinga Global Small Cap Conference at 1:55 pm EST on Thursday, December 9, 2021.

December 3, 2021
·
3 min read
H.C. Wainwright 2nd Annual Psychedelics Conference, BACK TO THE FUTURE!

BetterLife Pharma Inc. is pleased to announce that Dr. Ahmad Doroudian will be participating in the H.C. Wainwright 2nd Annual Psychedelics Conference.

December 3, 2021
·
4 min read
Drug Development

Latest Phase 3 Data for First-in-Class TREMFYA® (guselkumab) Demonstrates Significant and Durable Improvement in Signs and Symptoms of Active Psoriatic Arthritis

The COSMOS study met its primary endpoint, with a significantly higher proportion of TREMFYA-treated patients (44.4 percent) versus placebo-treated patients (19.8 percent) achieving ACR20 response at week 24.

December 3, 2021
·
19 min read
Business

Regulus Appoints Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceutical Development

Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced the appointment of Mohammad Ahmadian, Ph.D., as Vice President, Chemistry and Pharmaceutical Development.

December 3, 2021
·
4 min read